To print this page click the PRINT icon on your browser.

This page represents a printable version of the following page:
http://www.lrf.org.uk/en/1/discmlpapers.html		Leukaemia Research Fund
*information and education
**
*Diseases
*
*Chronic Myeloid Leukaemia Papers
**
*
*Full text available
The following papers are all listed within the Medline database as being available as a free download (full text) from the web. If any of them are not so available, please do not contact the Fund as we do not control the content of Medline.
Last updated 14/11/2008

resource icon*Chronic myeloid leukemia in 2006: a perspective
Mauro, M. J. and Deininger, M. W.
Haematologica 91 2006 152
resource icon*Management of Early Stage Disease
Michael W.N. Deininger
Hematology. American Society of Hematology Education Book 2005 174-182
resource icon*Loss of Response to Imatinib: Mechanisms and Management
Neil P. Shah
Hematology. American Society of Hematology Education Book 2005 183-187
resource icon*Pathobiology of Lymphoid and Myeloid Blast Crisis and Management Issues
Robert L. Ilaria, Jr
Hematology. American Society of Hematology Education Book 2005 188-194
resource icon*Survival advantage with imatinib mesylate therapy in chronic-phase chronic myelogenous ;eukemia (CML-CP) after IFN-alpha failure and in late CML-CP, comparison with historical controls
Kantarjian, H., O'Brien, S., Cortes, J., Giles, F., Shan, J., Rios, M. B., Faderl, S., Verstovsek, S., Garcia-Manero, G., Wierda, W., Kornblau, S., Ferrajoli, A., Keating, M., and Talpaz, M.
Clin Cancer Res. 10 1-1-2004 68-75
resource icon*Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia
Donato, N. J., Wu, J. Y., Stapley, J., Lin, H., Arlinghaus, R., Aggarwal, B. B., Shishodia, S., Albitar, M., Hayes, K., Kantarjian, H., and Talpaz, M.
Cancer Res. 64 15-1-2004 672-677
resource icon*Imatinib therapy for patients with chronic myelogenous leukemia: are patients living longer?
DeAngelo, D. J. and Ritz, J.
Clin Cancer Res. 10 1-1-2004 1-3
resource icon*Immunological effects of donor lymphocyte infusion in patients with chronic myelogenous leukemia relapsing after bone marrow transplantation
Castro, F. A., Palma, P. V., Morais, F. R., and Voltarelli, J. C.
Braz.J Med Biol.Res. 37 2004 201-206
resource icon*Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature
Ali, R., Ozkalemkas, F., Ozkocaman, V., Ozcelik, T., Ozan, U., Kimya, Y., and Tunali, A.
Jpn.J Clin Oncol 34 2004 215-217
resource icon*Optimizing treatment of chronic myeloid leukemia: a rational approach
Stone,R.M.
The Oncologist 9 2004 259-270
resource icon*Indications for Imatinib Mesylate therapy and clinical management
Guilhot,F.
The Oncologist 9 2004 271-281
resource icon*Chronic myelogenous leukemia
Druker, B. J., O'Brien, S. G., Cortes, J., and Radich, J.
Hematology (Am.Soc.Hematol Educ.Program.) 2002 111-35,
resource icon*Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis
Dalziel, K., Round, A., Stein, K., Garside, R., and Price, A.
Health Technol.Assess. 8 2004 iii, 1-iii120
resource icon*The effectiveness and cost-effectiveness of imatinib in chronic myeloid leukaemia: a systematic review
Garside, R., Round, A., Dalziel, K., Stein, K., and Royle, P.
Health Technol.Assess. 6 2002 1-162,
resource icon*The use of imatinib (STI571) in chronic myelod leukemia: some practical considerations
Marin, D., Marktel, S., Bua, M., Armstrong, L., Goldman, J. M., Apperley, J. F., and Olavarria, E.
Haematologica 87 2002 979-88,
resource icon*Chronic myelogenous leukemia
Druker, B. J., Sawyers, C. L., Capdeville, R., Ford, J. M., Baccarani, M., and Goldman, J. M.
Hematology (Am.Soc.Hematol Educ.Program.) 2001 87-112,
resource icon*Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities
Jonasch, E. and Haluska, F. G.
Oncologist 6 2001 34-55,
resource icon*The molecular biology of chronic myeloid leukemia
Deininger, M. W., Goldman, J. M., and Melo, J. V.
Blood 96 15-11-2000 3343-56,
resource icon*Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis
Di Bacco, A., Keeshan, K., McKenna, S. L., and Cotter, T. G.
Oncologist 5 2000 405-15,


*Medline searches
It is not possible to list all papers on this topic. The Medline link in the menu at the left will open a page which will allow you to search Medline for all papers on this topic, for all papers on a specific aspect of this topic or to apply limits to either of these searches to ensure a manageable number of responses. Because Medline contains many millions of papers, an unrestricted search may return a huge number of hits. It is advised that you carry out searches limited to the last 6 to 12 months initially as you can easily repeat the search with no limits.
Registered charity 216032. ©Leukaemia Research Fund 2008